Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study.
about
Role of gemcitabine in cancer therapy.Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.Role of gemcitabine in the treatment of ovarian cancer.
P2860
Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gemcitabine combined with cisp ...... rian cancer: a phase II study.
@ast
Gemcitabine combined with cisp ...... rian cancer: a phase II study.
@en
type
label
Gemcitabine combined with cisp ...... rian cancer: a phase II study.
@ast
Gemcitabine combined with cisp ...... rian cancer: a phase II study.
@en
prefLabel
Gemcitabine combined with cisp ...... rian cancer: a phase II study.
@ast
Gemcitabine combined with cisp ...... rian cancer: a phase II study.
@en
P2093
P1433
P1476
Gemcitabine combined with cisp ...... rian cancer: a phase II study.
@en
P2093
I Krakowski
J Janssens
L Kayitalire
M Beauduin
S Gauthier
P356
10.1016/S0090-8258(03)00413-X
P407
P577
2003-10-01T00:00:00Z